Infectious Disease Diagnostics Market

Product Launches and Approvals are the Key Growth Strategies Adopted by Market Players in the Infectious Disease Diagnostics Market

The major players operating in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMérieux (France), Bio-Rad (US), and Roche (Switzerland). The global infectious disease diagnostics market is expected to reach USD 19.35 Billion by 2022 from USD 14.73 Billion in 2017, at a CAGR of 5.6%. The increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics are the major factors driving the growth of the infectious disease diagnostics market.

Most companies focus on product launches and approvals to compete in the market. The players also focus on increasing their presence in high-growth markets through acquisitions, agreements, partnerships, collaborations, and expansions. Abbott (US), Becton, Dickinson and Company (BD) (US), biomérieux (France), Bio-Rad (US), and Roche (Switzerland) focus on product launches and approvals to strengthen their positions in the market.

Roche is the leading player in the infectious diagnostics market and offers different test kits and systems. The company mainly focuses on organic strategies like R&D investment and product launches & approvals. The company has R&D sites in 22 locations. In 2016, the company invested ~13% of its total revenue in R&D to come up with new product offerings. The company also focuses on collaborations, for instance, Roche entered into a strategic partnership with GE Healthcare to develop digital clinical decision solutions.

Abbott is one of the leading players in the global infectious disease diagnostics market. The company offers a wide range of products including assays & reagents and informatics solutions & services. Abbott focuses on strengthening its position in the market by adopting organic and inorganic strategies such as product launches, acquisitions, collaborations, and expansions. With its strong geographic presence and extensive product portfolio, the company is expected to witness significant growth in the infectious disease diagnostics market during the forecast period.

Danaher stands among the leading players in the infectious disease diagnostics market. The company offers analytical instruments, reagents, consumables, and software through its subsidiaries Beckman Coulter and Cepheid. In November 2016, Danaher acquired Cepheid (US) to expand its diagnostics business with Cepheid’s molecular diagnostic systems and tests. The company’s broad product portfolio and focus on improving its R&D capabilities to introduce new products into the market is expected to help the company maintain and enhance its position in the market.

Related Reports:

Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Report Code
MD 3088
Published ON
Apr, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Infectious Disease Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved